Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics: The Minimum Inhibitory Concentration versus Stationary Concentration

By Johan W. Mouton  

Clinical Pharmacokinetics, Vol. 44, Iss. 2, 2005-01 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

Clinical Use of Ceftriaxone: A Pharmacokinetic-Pharmacodynamic Perspective on the Impact of Minimum Inhibitory Concentration and Serum Protein Binding

By Perry T.R.   Schentag J.J.  

Clinical Pharmacokinetics, Vol. 40, Iss. 9, 2001-01 ,pp. : 685-694

Adis International

Access to resources Recommend Favorite

Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 3, 2008-07 ,pp. : 169-179

Bentham Science Publishers

Access to resources Recommend Favorite

Basis of Anti-Infective Therapy: Pharmacokinetic-Pharmacodynamic Criteria and Methodology for Dual Dosage Individualisation

By Sánchez-Navarro A.   Sánchez Recio M.M.  

Clinical Pharmacokinetics, Vol. 37, Iss. 4, 1999-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

Pyrimidines as Anti-Infective Agents

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 2, Iss. 4, 2003-12 ,pp. : 269-286

Bentham Science Publishers

Access to resources Recommend Favorite